All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The luteinizing hormone/choriogonadotropin receptor (LHCGR), also called lutropin/choriogonadotropin receptor (LCGR) or luteinizing hormone receptor (LHR) is a transmembrane receptor found predominantly in the ovary and testis, but also many extragonadal organs such as the uterus and breasts. The receptor interacts with both luteinizing hormone (LH) and chorionic gonadotropins (such as hCG in humans) and represents a G protein-coupled receptor (GPCR). Its activation is necessary for the hormonal functioning during reproduction.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LC245 | Anti-LHR (8B7-3) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | 8B7-3 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-LC246 | Anti-LHR (5F4-21) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | 5F4-21 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-LC247 | Anti-LHR (5B1-1) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | 5B1-1 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-LC248 | Anti-LHR (2H11-37) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2H11-37 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-LC249 | Anti-LHR (138-2) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | 138-2 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION